In a formal ceremony that took place in downtown Vancouver, BC, on 13 April 2024,…
karnottMay 9, 2024
Canada’s Immuno-Engineering and Biomanufacturing Hub Research Teams Awarded $140M in Federal Funding
Today, the Government of Canada announced an investment of $140 million in projects associated with…
karnottMay 8, 2024
Growing a robust, competitive, domestic biomanufacturing and life sciences sector ensures that Canada has access…
karnottMay 7, 2024
Cell-based cancer immunotherapy has achieved significant advancements, providing a source of hope for cancer patients.…
karnottMay 7, 2024
A Scandinavian collaboration has taken another step towards generating universal blood that is suitable for…
karnottMay 6, 2024
Alumni of the UBC Graduate Program in Neuroscience (GPN) embark on diverse career paths, spanning…
karnottMay 3, 2024
Pancreatic neuroendocrine neoplasms (PNENs) are malignant tumors that arise from clusters of islet cells—the part of the…
pthomsonOctober 27, 2021
More than 80 percent of people with Parkinson’s disease suffer from a reduced sense of…
pthomsonOctober 27, 2021
Although the human genome was first sequenced three decades ago, to this day, there are…
pthomsonOctober 26, 2021
Imagine a procedure that could reverse the effects of Type 1 diabetes by implanting in…
pthomsonOctober 25, 2021
Just six years since leaving Cambridge, Brianne Kent has secured a role as Assistant Professor,…
pthomsonOctober 25, 2021
Warding Off the Post-Antibiotic Era: Stimulating the Pursuit to Visualize a Common Antibiotic Target
Antibiotics are used to treat bacterial infections by killing or inhibiting the growth of bacteria.…
pthomsonOctober 25, 2021
Inborn errors of immunity (IEIs) are a group of over 430 genetic disorders that result…
pthomsonOctober 22, 2021
APEIRON Biologics AG, a privately held biotechnology company founded by LSI Director Dr. Josef Penninger…
pthomsonOctober 22, 2021
